ONCONEUROAXIS Trademark

Trademark Overview

On Monday, April 20, 2026, a trademark application was filed for ONCONEUROAXIS with the United States Patent and Trademark Office. The USPTO has given the ONCONEUROAXIS trademark a serial number of 99774580. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 20, 2026. This trademark is owned by OncoNeuroX Therapeutics LLC. The ONCONEUROAXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research in the field of neurodegenerative diseases, cancer, and their shared biological mechanisms
onconeuroaxis

General Information

Serial Number99774580
Word MarkONCONEUROAXIS
Filing DateMonday, April 20, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkONCOLOGY NEURO AXIS
Pseudo MarkONCO NEUROAXIS
Pseudo MarkONCOLOGY NEUROAXIS
Pseudo MarkONCO NEURO AXIS
Goods and ServicesMedical research in the field of neurodegenerative diseases, cancer, and their shared biological mechanisms

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 20, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOncoNeuroX Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSAN DIEGO, CA 92121
US

Trademark Events

Event DateEvent Description
Monday, April 20, 2026NEW APPLICATION ENTERED
Monday, April 20, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

onconeuroaxis their shared biological mechanisms cancer diseases research field neurodegenerative medical